The features of adipose-derived stem cells in patients with inflammatory bowel diseases.

Tsunekazu MizushimaTadafumi FukataHiroshi TakeyamaHidekazu TakahashiNaotsugu HaraguchiJunichi NishimuraTaishi HataChu MatsudaHirofumi YamamotoYuichiro DokiMasaki Mori

Published in: Surgery today (2017)

These results showed the potential advantage of freshly isolated autologous ADSCs in IBD patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
mesenchymal stem cells
patient reported